American Coryn Rivera took the win at the UCI 2.2 Tour Féminin en Limousin today when she outsprinted her breakmates at the end of the 120 km stage 1. Sofie de Vuyst (Lotto Honda) was second and defending champion Grete Treire (S.C. Michela Fanini Rox), third.
“It was good. I was in the front and then I crashed and I had to get back on. It took me a while for me to get it together.” Rivera told france 3. “There were last minute flyers in the breakaway and I just kept riding and riding. On the last corner, I jumped them, sprinted to the line and won.”
This makes the first European victory for the 18-year old who has won 32 US National Championships in her career, so far, including the USA U23 National Criterium Championships last month.
Rivera has a four-second lead on de Vuyst going into tomorrow’s time trial. She also leads the Best Young Rider classification.
The peloton stayed together for the first four laps of 20km after enduring a slew of flat tires on the wet roads on the first lap. The first real attack, after 80 kilometers once the roads dried under the sun following a rainy morning, included many of the pre-race favorites such as 2009 overall winner Grace Verbeke (Belgium National Title), winner of two stages at the Tour de Bretagne, Rhae-Christie Shaw (Canada National Team) and winner of the overall at the Tour de Bretagne, Alexandra Buchenkova (Russia National Team). Also making the split were Flavia Oliviera (Vaiano Solaristech), Petra Djkman (Dolmans Landscaping Team), Treire, de Vuyst and Rivera who bridged up.
The eight worked together to push the gap up to two minutes but the cooperation stopped on the final lap. Attacks flew but nothing stuck and the sprint was for the stage win.
Verbeke leads the QOM classification and Martine Bras (Dolmans Landscaping Team) leads Sprint after one stage.
Racing continues tomorrow with the out-and-back 15-km time trial which includes two 180-turns close to the finish line. Saturday brings a four-lap, 126.3 km rolling stage followed by the hilly final 102.6 km stage.